Source: Virtual Congress 2020 – Advances in asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vianello (Padua (PD), Italy), G. Guarnieri (Padua (PD), Italy), B. Molena (Padua (PD), Italy), N. Malacchini (Padua (PD), Italy), F. Chieco Bianchi (Padua (PD), Italy), I. Ferrarotti (Pavia (PV), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy). Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma. 2624

Member's Comments

No comment yet.

Related content which might interest you: Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Predictors of accelerated decline in lung function in adult-onset asthma Source: Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017 Year: 2018 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Exacerbations and duration of smoking abstinence are associated with the annual decline in lung function in individuals with PiZZ alpha-1-antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019 Year: 2020 Exploring the relationship between alpha-1-antitrypsin deficiency and persistent airflow limitation in severe asthma. Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Influence of obesity on pulmonary function (PF) in severe asthmatic children Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011 Intermediate and severe α1-antitrypsin deficiency: influence on plasma α1-antitrypsin, FEV1 and risk of COPD. Three meta-anlyses Source: Eur Respir J 2002; 20: Suppl. 38, 513s Year: 2002 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort Source: Eur Respir J 2006; 28: Suppl. 50, 160s Year: 2006 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Accelerated decline in lung function in adults with a history of remitted childhood asthma Source: Eur Respir J, 59 (1) 2100305; 10.1183/13993003.00305-2021 Year: 2022 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Influence of β2-adrenoceptor genotype on risk of asthma worsening using fluctuation analysis of lung function Source: Eur Respir J 2007; 30: Suppl. 51, 447s Year: 2007 Association of wheeze with lung function decline in children with sickle cell disease Source: Eur Respir J, 50 (5) 1602433; 10.1183/13993003.02433-2016 Year: 2017 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 205s Year: 2001